On September 30, 2021, Dr.
Gene Salkind (and Catherine Salkind) converted 1,500 shares of Series C Preferred Stock into 375,000 shares of common stock and warrants
to purchase an additional 375,000 shares of common stock. These warrants are exercisable at $48 per share through September 20, 2023.
Exemption from registration is claimed under Section 3(a)(9) of the Securities Act of 1933, as amended, as an exchange of securities of
the same issuer without any compensation being paid.
Pursuant to the requirements
of the Securities Exchang e Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
MOBIQUITY TECHNOLOGIES, INC.
Date: October 4, 2021
/s/ Dean Julia
Chief Executive Officer
makes a similar move, sign up!